Fidson Healthcare

Fidson Healthcare Current Liabilities

Current Liabilities of Fidson Healthcare (FIDSON.NL) as of Oct 31, 2026.

Current Liabilities

-NGN

Last updated:

Current Liabilities of Fidson Healthcare is 2026 - NGN. Current Liabilities of Fidson Healthcare was 2025 - NGN. It decreases by % lower compared to the previous year.

The Fidson Healthcare Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2016
6.64 B NGN
Jan 1, 2017
7.09 B NGN
Jan 1, 2018
10.54 B NGN
Jan 1, 2019
6.12 B NGN
Jan 1, 2020
9.55 B NGN
Jan 1, 2021
10.97 B NGN
Jan 1, 2022
18.01 B NGN
The Fidson Healthcare Current Liabilities history
YEARCurrent LiabilitiesYoY
18.01 BNGN+64.16%
10.97 BNGN+14.90%
9.55 BNGN+56.09%
6.12 BNGN-41.94%
10.54 BNGN+48.63%
7.09 BNGN+6.71%
6.64 BNGN—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Fidson Healthcare Stock analysis

What does Fidson Healthcare do? Fidson Healthcare Plc manufactures and distributes pharmaceutical products, including drugs, infusion and injectables, across its segments: over-the-counter, ethical products, and consumer. The over-the-counter segment sells products directly to consumers without prescriptions, while the ethical products segment offers prescription-only drugs, injectables, and infusions. The consumer segment focuses on household items. The company provides formulation/development, contract manufacturing, and production services for medicines. Its product portfolio includes Anti Infective & Anti Malaria, Central Nervous System (CNS), Gastrointestinal Medicines, Supplements, Topical/Dermatological Medicines, Vitamins & Minerals, Ophthalmic Solution, and others, with Ophthalmic Solution specifically targeting eye conditions. The company's primary revenue streams come from the sale of pharmaceutical products within its three segments. Over-the-counter products are purchased by general consumers, ethical products are bought by healthcare providers and pharmacies requiring prescriptions, and consumer segment items are sold to households. Fidson Healthcare Plc serves the Nigerian market through its manufacturing and distribution network, leveraging its full-time workforce of 593 employees to support operations. Fidson Healthcare Plc's product lines are tailored to specific market needs, with Anti Infective & Anti Malaria products addressing infectious diseases, CNS medications targeting neurological disorders, and Ophthalmic Solution treating eye conditions. The company's services in formulation/development and contract manufacturing further generate revenue by supporting other pharmaceutical firms in product creation and production. Fidson Healthcare is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Fidson Healthcare stock

On Eulerpool you can find the complete historical development of Current Liabilities Fidson Healthcare since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's NGN is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Fidson Healthcare historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Fidson Healthcare

All Key Metrics — Fidson Healthcare